Table 2:

HR for mortality per 5 mmHg increase in BP during follow-up (joint models).

BP	Crude HR (95% CI)	P-value	aHR (95% CI)	P-value
Systolic
Pre	0.97 (0.95–1.00)	.03	0.97 (0.94–0.99)	.01
Post	0.99 (0.96–1.02)	.62	0.95 (0.92–0.98)	.002
Δ	1.03 (0.99–1.08)	.14	0.98 (0.94–1.03)	.45
Diastolic
Pre	0.86 (0.82–0.90)	<.0005	0.98 (0.93–1.02)	.31
Post	0.82 (0.77–0.86)	<.0005	0.94 (0.88–1.00)	.03
Δ	1.02 (0.94–1.11)	.61	0.88 (0.80–0.97)	.01
MAP
Pre	0.89 (0.86–0.93)	<.0005	0.97 (0.93–1.01)	.10
Post	0.89 (0.85–0.94)	<.0005	0.93 (0.88–0.98)	.004
Δ	1.04 (0.98–1.11)	.23	0.94 (0.88–1.01)	.09
Pulse pressure
Pre	1.04 (1.01–1.07)	.01	0.96 (0.93–0.99)	.02
Post	1.06 (1.03–1.10)	.0002	0.96 (0.93–1.00)	.05
Δ	1.07 (0.97–1.15)	.17	1.01 (0.93–1.10)	.73

Models were adjusted for age, gender, history of CVD, dialysis vintage, BMI and diabetes.